BDTX — Black Diamond Therapeutics Share News
0.000.00%
Last trade - 00:00- $100.28m
- -$17.98m
- $70.00m
Brief: Black Diamond Publishes New Analyses of HER2 Mutations Based on Proprietary MAP Discovery Engine
Black Diamond Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
Brief: Black Diamond Therapeutics Says Cash Runway Extended Into Q3 2024
Black Diamond Therapeutics Inc expected to post a loss of 75 cents a share - Earnings Preview
Brief: Black Diamond Therapeutics Reports Pipeline Prioritization, Workforce Realignment
Brief: Black Diamond Therapeutics Announces First Patient Dosed In Phase 1 Study Of BDTX-1535
U.S. RESEARCH ROUNDUP- Astec Industries, ChampionX, Schlumberger NV
U.S. RESEARCH ROUNDUP-Costco Wholesale, Nielsen Holdings, Public Storage
Brief: Black Diamond Therapeutics Reports Q4 And FY 2021 Financial Results
Brief: Black Diamond Therapeutics Appoints Elizabeth Montgomery As Chief People Officer
U.S. STOCKS ON THE MOVE-Rivian, Tesla, Boeing, Aligos, Peloton
U.S. STOCKS ON THE MOVE-Vir Biotech, Phio Pharma, American Airlines
U.S. STOCKS ON THE MOVE-Nikola, Illumina, Danaher, Shake Shack
Black Diamond rises as FDA clears cancer drug for clinical trials
Brief: Black Diamond Therapeutics Announces FDA Allowance Of IND Application For BDTX-1535
Brief: Black Diamond Therapeutics Announces Strategic Priorities And Expected Milestones For 2022
Brief: Black Diamond Therapeutics CFO Thomas Leggett Resigns
Black Diamond Therapeutics Inc reports results for the quarter ended in September - Earnings Summary
Brief: Black Diamond Therapeutics Reports Qtrly Net Loss Per Share Of $0.97